Level Biotechnology (3118) — Cash Flow Reinvestment Rate
Level Biotechnology (3118) has a Cash Flow Reinvestment Rate of 0.80x as of September 2025, reinvesting NT$9.45 Million (capex NT$4.44 Million plus investments NT$-5.01 Million) from operating cash flow of NT$11.81 Million. See Level Biotechnology free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Level Biotechnology Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Level Biotechnology across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Level Biotechnology.
Annual Cash Flow Reinvestment Rate for Level Biotechnology (2017–2024)
Year-by-year capital reinvestment analysis for Level Biotechnology. See 3118 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.57x | NT$228.80 Million | NT$64.10 Million | NT$223.68 Million | ▲ +1249.9% |
| 2023 | 0.26x | NT$18.57 Million | NT$70.21 Million | NT$7.67 Million | ▲ +1.7% |
| 2022 | 0.26x | NT$16.93 Million | NT$65.07 Million | NT$6.74 Million | ▲ +317.3% |
| 2021 | 0.06x | NT$9.72 Million | NT$155.95 Million | NT$9.15 Million | ▲ +67.0% |
| 2020 | 0.04x | NT$3.11 Million | NT$83.23 Million | NT$2.54 Million | ▲ +36.0% |
| 2019 | 0.03x | NT$2.99 Million | NT$109.02 Million | NT$2.43 Million | ▼ -76.1% |
| 2018 | 0.11x | NT$3.08 Million | NT$26.77 Million | NT$2.51 Million | ▼ -78.3% |
| 2017 | 0.53x | NT$37.79 Million | NT$71.29 Million | NT$10.83 Million | — |